TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 43 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $995,000 | +2.6% | 1,000,000 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $970,000 | +0.2% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $968,000 | +4.5% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $926,000 | -2.3% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $948,000 | +4.8% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $905,000 | -59.6% | 1,000,000 | -59.2% | 0.00% | -50.0% |
| Q2 2019 | $2,240,000 | -65.3% | 2,450,000 | -65.0% | 0.00% | -66.7% |
| Q1 2019 | $6,454,000 | -43.2% | 7,000,000 | -44.4% | 0.01% | -50.0% |
| Q4 2018 | $11,372,000 | +15.8% | 12,600,000 | +20.0% | 0.01% | +33.3% |
| Q3 2018 | $9,820,000 | +41.3% | 10,500,000 | +40.0% | 0.01% | +28.6% |
| Q2 2018 | $6,952,000 | +32.2% | 7,500,000 | +25.0% | 0.01% | +40.0% |
| Q1 2018 | $5,259,000 | -30.3% | 6,000,000 | -30.2% | 0.01% | -28.6% |
| Q4 2017 | $7,547,000 | +10.2% | 8,600,000 | +13.2% | 0.01% | 0.0% |
| Q3 2017 | $6,850,000 | -35.5% | 7,600,000 | -23.2% | 0.01% | -30.0% |
| Q2 2017 | $10,619,000 | -34.9% | 9,900,000 | -34.9% | 0.01% | -33.3% |
| Q1 2017 | $16,321,000 | -22.4% | 15,200,000 | -20.8% | 0.02% | -28.6% |
| Q4 2016 | $21,024,000 | +518.4% | 19,200,000 | +573.7% | 0.02% | +600.0% |
| Q3 2016 | $3,400,000 | -1.7% | 2,850,000 | +4210.3% | 0.00% | -25.0% |
| Q2 2016 | $3,459,000 | -52.5% | 66,120 | -98.8% | 0.00% | -55.6% |
| Q1 2016 | $7,286,000 | -45.8% | 5,600,000 | -34.9% | 0.01% | -40.0% |
| Q4 2015 | $13,437,000 | +9.8% | 8,607,000 | -4.6% | 0.02% | 0.0% |
| Q3 2015 | $12,235,000 | -4.0% | 9,021,000 | -1.1% | 0.02% | +25.0% |
| Q2 2015 | $12,747,000 | -40.1% | 9,121,000 | -36.6% | 0.01% | -45.5% |
| Q1 2015 | $21,295,000 | +2.2% | 14,389,000 | -5.6% | 0.02% | +15.8% |
| Q4 2014 | $20,836,000 | -26.4% | 15,250,000 | -30.8% | 0.02% | -17.4% |
| Q3 2014 | $28,300,000 | +2.1% | 22,045,000 | +1.7% | 0.02% | 0.0% |
| Q2 2014 | $27,716,000 | +9.8% | 21,685,000 | +9.0% | 0.02% | -8.0% |
| Q1 2014 | $25,248,000 | +145.4% | 19,890,000 | +105.3% | 0.02% | +177.8% |
| Q4 2013 | $10,290,000 | +2.3% | 9,690,000 | -0.1% | 0.01% | -10.0% |
| Q3 2013 | $10,059,000 | -12.7% | 9,700,000 | -11.8% | 0.01% | -16.7% |
| Q2 2013 | $11,522,000 | +41.5% | 11,000,000 | +40.4% | 0.01% | +50.0% |
| Q1 2013 | $8,145,000 | – | 7,836,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |